# US 2012/0237959 A1 · Tumor endothelial marker 5-alpha molecules and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0237959 A1
- Document ID: US20120237959A1
- Status: Published application
- Kind: A1
- Application number: 13/432,592
- Filed: 2012-03-28
- Published: 2012-09-20
- Earliest claimed: 2001-10-12
- Assignees: Amgen Inc.
- Inventors: Todd Juan
- Web page: https://patentgrep.com/patent/US20120237959A1

## CPC

- C07K 14/4748: {Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE}
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 35/00: Antineoplastic agents
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present invention provides Tumor Endothelial Marker 5α (TEM5α) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TEM5α polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, or prevention of diseases, disorders, and conditions associated with TEM5α polypeptides.

## Claims

### Claim 1

A method of determining an amount of TEM5α polypeptide present in a sample comprising:
(a) contacting the sample with a detectably labeled antibody that specifically binds to SEQ ID NO:2 or 4; and
(b) determining the amount of antibody bound to the sample; and
(c) correlating the amount of antibody bound to the sample with the amount of TEM5α present in the sample.

### Claim 2 (depends on 1)

The method of claim 1, wherein the method comprises a component of a competitive binding assay.

### Claim 3 (depends on 1)

The method of claim 1, wherein the method comprises a component of a direct sandwich assay.

### Claim 4 (depends on 1)

The method of claim 1, wherein the assay comprises a component of an indirect sandwich assay.

### Claim 5 (depends on 1)

The method of claim 1, wherein the assay comprises a component of an immunoprecipitation assay.

### Claim 6 (depends on 1)

The method of claim 1, wherein the detectable label comprises a fluorescent moiety.

### Claim 7 (depends on 1)

The method of claim 1, wherein the detectable label comprises a radiolabel.
